NVIV Chart
- 52-Week Range: $3.52 - $20.25
- Market Capitalization: $6.32M
- Short Percentage: 0%
- Target Price: $37.50
- Shares Outstanding: 1.39M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
NVIV released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright BioConnect ConferenceBusiness Wire | January 6th
- InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment ConferenceBusiness Wire | September 9th
- InVivo Therapeutics Announces 75% Target Enrollment Achieved for the INSPIRE 2.0 Spinal Cord Injury StudyBusiness Wire | September 8th
Company Info
Website: https://www.invivotherapeutics.com
Address: One Kendall Square, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: N/A
Address: One Kendall Square, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: N/A
$NVIV Hold on to your Butts.
$NVIV omg this is bullshit
$NVIV NOT SELLING.
$NVIV get over the hump
$NVIV when this finally break out we could see huge upside
$NVIV Fake dip news.
$NVIV Green by EOD guarentee
$NVIV I like it
$NVIV hi hi
$NVIV omg this is bullshit